Loading...
XNAS
CDIOW
Market cap7mUSD
Jul 24, Last price  
0.01USD
1D
2.85%
1Q
-51.16%
IPO
-90.21%
Name

Cardio Diagnostics Holdings Inc

Chart & Performance

D1W1MN
P/E
P/S
0.73
EPS
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
%
Revenues
35k
+104.45%
090195017,06534,890
Net income
-8m
L+0.08%
-605,164-620,448-4,660,985-8,376,834-8,383,453
CFO
-5m
L-11.97%
25,859-585,291-5,090,968-5,672,175-4,993,104

Profile

Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.
IPO date
Nov 23, 2021
Employees
7
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑12
Income
Revenues
35
104.45%
17
1,696.32%
950
5.44%
Cost of revenue
8,381
7,240
4,549
Unusual Expense (Income)
NOPBT
(8,346)
(7,223)
(4,548)
NOPBT Margin
Operating Taxes
113
Tax Rate
NOPAT
(8,346)
(7,223)
(4,661)
Net income
(8,383)
0.08%
(8,377)
79.72%
(4,661)
651.23%
Dividends
Dividend yield
Proceeds from repurchase of equity
12,547
390
11,986
BB yield
-55.98%
-1.23%
-366.22%
Debt
Debt current
237
598
849
Long-term debt
1,089
1,550
Deferred revenue
Other long-term liabilities
Net debt
(6,501)
865
(3,268)
Cash flow
Cash from operating activities
(4,993)
(5,672)
(5,091)
CAPEX
(215)
(576)
(76)
Cash from investing activities
(404)
(794)
(368)
Cash from financing activities
11,941
3,632
9,064
FCF
(7,634)
(6,992)
(7,022)
Balance
Cash
7,827
1,284
4,118
Long term investments
Excess cash
7,826
1,283
4,117
Stockholders' equity
(22,751)
(14,368)
(5,991)
Invested Capital
32,972
18,587
13,090
ROIC
ROCE
EV
Common stock shares outstanding
24,443
12,685
3,088
Price
0.92
-63.17%
2.49
134.91%
1.06
 
Market cap
22,414
-29.04%
31,586
865.06%
3,273
 
EV
15,913
32,451
4
EBITDA
(8,232)
(7,112)
(4,532)
EV/EBITDA
Interest
19
6,735
Interest/NOPBT